Brian Padden is a senior news correspondent in the Voice of America News Center in Washington, D.C. He recently spent four years as the VOA’s Seoul News Bureau Chief, where he primarily covered North Korea’s accelerated nuclear buildup and its diplomatic pivot. He also worked for three years as the Jakarta Bureau Chief for VOA, where he reported on natural disasters, fragile democracies, and Islamic extremism in Southeast Asia.
But for most of his long career with VOA, Brian was based in Washington, D.C., and traveled around the world, often at a moment’s notice, to cover breaking news, such as democracy protests in Hong Kong, conflicts in Kosovo, Afghanistan, Iraq and Ukraine, or important events such as elections in Venezuela or the Olympics in China.
Brian was born and raised in Levittown, Pennsylvania, studied radio/TV/film at Temple University, and in 1980 joined the Peace Corps, where he spent three years working on educational television projects in Paraguay.
With the global COVID-19 death toll surging past 23,000 people this week, accelerated efforts to develop coronavirus treatments are primarily focused on adapting existing drugs intended to fight other diseases. VOA’s Brian Padden reports that the medications being tested focus on three areas: neutralizing the virus itself, alleviating some of its life-threatening symptoms, and boosting a patient’s immune system to fight off infection.
Vermont Senator Bernie Sanders reportedly is reassessing his presidential campaign after former Vice President Joe Biden’s dominating primary election victories this week effectively closed off any realistic path for Sanders to win the Democratic nomination. However, as VOA’s Brian Padden reports, many of Sanders’ most ardent supporters are unwilling to abandon their candidate’s progressive agenda - especially during the coronavirus pandemic.